- Help
- •Contact us
- •About us
- •Sitemap
- •Advertise with the FT
- •Terms & conditions
- •Privacy policy
- •Copyright
© The Financial Times Ltd 2012 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
6:00pm
Dec 5, 2012
Drugs groups aim to halve cost of trials
Move comes as sales of new medicines slows
- Cost of developing drugs jumps tenfold
- Undercover Economist Unloading the dice on research
Dec 4, 2012
Patent expiries trigger pain drugs battle
Generic drug companies want to sell copies of narcotic painkillers
- Intellectual property Patent lore
- Novartis offsets effects of patent expiry
Dec 2, 2012
Cost of developing drugs jumps tenfold
Study stresses regulatory hurdles and return on capital demands
Dec 2, 2012
Allergan obesity business attracts buyers
The company produces Lap Band gastric devices, which constrict the stomach to reduce appetite
From
INDUSTRIALS
Dec 2, 2012
Tax threat prompts US dealmaking flurry
Companies rush to close deals as fiscal cliff deadline looms
- First Quantum hurt by Inmet’s rejection
- Number Cruncher Britvic’s bitter aftertaste
From
INDUSTRIALS
Dec 1, 2012
SThree to consolidate existing locations
White-collar recruiter is to slow its expansion into emerging markets
The Top Line
from
MEDIA
Nov 30, 2012
‘Tis the season to be wary as gifts roll in
Great deal of evidence that gifts induce co-operation
Nov 28, 2012
Nestlé health unit seeks Chinese remedy
Group in joint venture with traditional medicine company
Nov 28, 2012
Outsourced drug trials lack oversight, study says
Analysis highlights gaps in the system of testing
Nov 27, 2012
Chinese genetics group defends US bid
Rival bidder warns of national security risks if deal goes ahead
Nov 26, 2012
GSK to take greater control of subsidiaries
UK drugs group invests ₤650m in Indian and Nigerian units
Nov 23, 2012
Doctors tread warily over insider trading
FBI focus on pharmaceutical sector leads to ‘expert network’ concerns
Nov 23, 2012
University botanic gardens threatened
Danger from cash cuts and changing research trends
Nov 22, 2012
Roche pledges to release Tamiflu data
Move will allow greater scrutiny of drug’s efficacy
Nov 21, 2012
BASF to fatten up nutrition arm
German group acquires Norwegian healthcare business Pronova
Nov 20, 2012
Bayer move boosts Reckitt’s Schiff bid
German group refuses to raise price for nutrition company
Multimedia
Offers
JOIN THE BUSINESS ELITEMore people at the top read the FT*
*FT has grown in every major readership survey in 2010
*FT has grown in every major readership survey in 2010 COMPANIES NEWS ON TWITTER
More FT Twitter accounts
EDITOR’S CHOICE
IN DEPTH
MOST POPULAR IN COMPANIES
-
Strategic Supply Chain Manager - Major Bids
Engineering
-
Head of Information Security
Commerzbank
-
Project Director
FMCG / IT
-
Group Sales Director
Media
TOOLS & SERVICES
Multimedia
Tools
- Portfolio
- FT Lexicon
- FT clippings
- Currency converter
- MBA rankings
- Newslines
- Today's newspaper
- FT press cuttings
- FT ebooks
- FT ePaper
- Economic calendar
Baxter / Gambro – no adrenalin rush
The deal is a reflection of the new normal that large corporations and even equity investors face